Cargando…

Novel natural inhibitors targeting B-RAF(V600E) by computational study

The aim of this research was to screen the ZINC15 database to select lead compounds and drug candidates which can inhibit B-RAF (V600E). In order to identify drugs potentially inhibited B-RAF (V600E), numerous modules of Discovery Studio 4.5 were employed. Structure-based screening using LibDock was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Bo, Zhang, Zhiyun, Dou, Gaojing, Lv, Xiaye, Ge, Junliang, Wang, Hongyu, Xie, Haoqun, Zhu, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806850/ https://www.ncbi.nlm.nih.gov/pubmed/34252351 http://dx.doi.org/10.1080/21655979.2021.1943113

Ejemplares similares

Computational study on novel natural inhibitors targeting BCL2
por: Lv, Xiaye, et al.
Publicado: (2021)

Computational study of effective matrix metalloproteinase 9 (MMP9) targeting natural inhibitors
por: Liu, Naimeng, et al.
Publicado: (2021)

Computational study on novel natural inhibitors targeting c-MET
por: Hou, Yuanyuan, et al.
Publicado: (2021)

Identification of effective natural PIK3CA H1047R inhibitors by computational study
por: Liu, Naimeng, et al.
Publicado: (2021)

Identification of novel natural inhibitors targeting AKT Serine/Threonine Kinase 1 (AKT1) by computational study
por: Zhong, Sheng, et al.
Publicado: (2022)

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
por: Poulikakos, Poulikos I., et al.
Publicado: (2011)

The mechanism of activation of monomeric B-Raf V600E
por: Maloney, Ryan C., et al.
Publicado: (2021)

Activation mechanisms of clinically distinct B‐Raf V600E and V600K mutants
por: Zhang, Mingzhen, et al.
Publicado: (2022)

Melanoma whole exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance
por: Shi, Hubing, et al.
Publicado: (2012)

Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAF(V600E)-Mutant Human Glioma
por: Schreck, Karisa C., et al.
Publicado: (2021)

Suppression of B-Raf(V600E) cancers by MAPK hyper-activation
por: Atiq, Rawan, et al.
Publicado: (2016)

Imidazothiazole-based potent inhibitors of V600E-B-RAF kinase with promising anti-melanoma activity: biological and computational studies
por: Anbar, Hanan S., et al.
Publicado: (2020)

Small molecules against B-RAF (BRAF) Val600Glu (V600E) single mutation
por: Zaharie, Florin, et al.
Publicado: (2015)

Discovery of New Quinolone-Based Diarylamides as Potent B-RAF(V600E)/C-RAF Kinase Inhibitors Endowed with Promising In Vitro Anticancer Activity
por: Kim, Hyun Ji, et al.
Publicado: (2023)

Differential sensitivity of melanoma cell lines with BRAF(V600E )mutation to the specific Raf inhibitor PLX4032
por: Søndergaard, Jonas N, et al.
Publicado: (2010)

Repositioning organohalogen drugs: a case study for identification of potent B-Raf V600E inhibitors via docking and bioassay
por: Li, Yisu, et al.
Publicado: (2016)

A Look Inside of the Complex Pathogenesis of B-RAF(V600E)-Driven Cancer
por: Caputo, Emilia
Publicado: (2017)

Selected ideal natural ligand against TNBC by inhibiting CDC20, using bioinformatics and molecular biology
por: Liu, Naimeng, et al.
Publicado: (2021)

The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury
por: Li, J-X, et al.
Publicado: (2014)

Analysis of the B-RAF(V600E) mutation in cutaneous melanoma patients with occupational sun exposure
por: CANDIDO, SAVERIO, et al.
Publicado: (2014)

B-RAF(V600E) Inhibitor Dabrafenib Attenuates RIPK3-Mediated Necroptosis and Promotes Functional Recovery after Spinal Cord Injury
por: Sugaya, Takehiro, et al.
Publicado: (2019)

Apoptosis of human melanoma cells induced by inhibition of B-RAF(V600E) involves preferential splicing of bim(S)
por: Jiang, C C, et al.
Publicado: (2010)

B-RafV600E inhibits sodium iodide symporter expression via regulation of DNA methyltransferase 1
por: Choi, Yong Won, et al.
Publicado: (2014)

BRAF V600E-mutated metastatic pediatric Wilms tumor with complete response to targeted RAF/MEK inhibition
por: Obasaju, Patience, et al.
Publicado: (2020)

A B‐Raf V600E gene signature for melanoma predicts prognosis and reveals sensitivity to targeted therapies
por: Yao, Kevin, et al.
Publicado: (2022)

BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
por: Del Bufalo, Francesca, et al.
Publicado: (2018)

Effective natural inhibitors targeting poly ADP-ribose polymerase by computational study
por: Zhong, Sheng, et al.
Publicado: (2021)

Oncogenic B-RAF(V600E) signaling induces the T-box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion
por: Boyd, Suzanah C., et al.
Publicado: (2012)

TSH Signaling Overcomes B-RafV600E–Induced Senescence in Papillary Thyroid Carcinogenesis through Regulation of DUSP6()()
por: Kim, Young Hwa, et al.
Publicado: (2014)

Computational study on natural compounds inhibitor of c-Myc
por: Ren, Junan, et al.
Publicado: (2020)

BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma
por: Wilmott, J S, et al.
Publicado: (2013)

Studies on [5,6]-Fused Bicyclic Scaffolds Derivatives as Potent Dual B-Raf(V600E)/KDR Inhibitors Using Docking and 3D-QSAR Approaches
por: Liu, Hai-Chun, et al.
Publicado: (2015)

The Hidden Story of Heterogeneous B-raf V600E Mutation Quantitative Protein Expression in Metastatic Melanoma—Association with Clinical Outcome and Tumor Phenotypes
por: Betancourt, Lazaro Hiram, et al.
Publicado: (2019)

Expression of B-RAF V600E in Type II Pneumocytes Causes Abnormalities in Alveolar Formation, Airspace Enlargement and Tumor Formation in Mice
por: Zanucco, Emanuele, et al.
Publicado: (2011)

The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia
por: Guerrini, Francesca, et al.
Publicado: (2016)

Critical role of miR-10b in B-Raf(V600E) dependent anchorage independent growth and invasion of melanoma cells
por: Datar, Ila, et al.
Publicado: (2019)

Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review
por: González-González, Rogelio, et al.
Publicado: (2020)

RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
por: Jin, Ting, et al.
Publicado: (2017)

Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells
por: Molnár, Eszter, et al.
Publicado: (2018)

BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients
por: Sun, Jian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7g7ivljbsc1sm91vpbji7cl73f